Merck, AG909, ADAM 17, control peptide for AB19027

General description
The peptide is used for blocking the activity of anti-TACE, C-Terminal (Catalog number AB19027). Incubate the peptide with equal volume of antibody for 30 minutes at 37oC to block the activity of anti-TACE in Western blotting. Amino Acids 807 to 823 (ASFKLQRQNRVDSKETE) of human TACE (Black et al. 1997; Moss et al. 1997).
Application
For use in blocking the reactivity of AB19027.

Optimal working dilution must be determined by the end user.
Physical form
Liquid in PBS containing 0.1% BSA and 0.02% sodium azide.
Preparation Note
Maintain at -20°C in undiluted aliquots for up to 12 months. Avoid repeated freeze/thaw cycles.
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.